Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MC220712 Phase 0/I Clinical Trial of the ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Recurrent High-Grade Glioma

NCT05917145 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05917145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05917145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MC220712 Phase 0/I Clinical Trial of the ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Recurrent High-Grade Glioma
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Recruiting
Start date
January 17, 2024
Completion date
May 31, 2029
Enrollment
94 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma